Bank Hapoalim B.M., (BKHPF) Fair Value & Analysis
Financial Services · US · Market cap $35.3B
Analysis
Bank Hapoalim B.M., (BKHPF) currently trades at $26.95, while our model-based Fair Value estimate is $32.56 — implying the stock looks roughly 20.8% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Bank Hapoalim B.M., together with its subsidiaries, provides various banking and financial services in Israel, North America, Europe, and internationally. It operates through Households, Private Banking, Small Businesses and Microbusinesses, Mid-sized Businesses, Large Businesses, Institutional Entities, Financial Management, and Other segments. The company offers account-management services, lending for various purposes, deposits and savings plans, and capital-market services; housing loans; research and advisory services; and pension advisory and retirement planning services. It also provides products and services for the expansion of a business, advanced digital services, and a service center; credit for routine operations and investment financing, guarantees, letters of credit, foreign trade, and transactions in financial and derivative instruments, as well as investment services in various channels, such as foreign currency, shekels, and securities. In addition, the company off…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.